Avanos Medical, Inc.
AVNS
$24.96
-$0.02-0.08%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 182.20M | 180.90M | 177.80M | 175.00M | 167.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 182.20M | 180.90M | 177.80M | 175.00M | 167.50M |
| Cost of Revenue | 88.00M | 94.90M | 91.80M | 82.90M | 77.70M |
| Gross Profit | 94.20M | 86.00M | 86.00M | 92.10M | 89.80M |
| SG&A Expenses | 76.80M | 89.40M | 77.20M | 83.50M | 75.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.40M | -1.40M | 2.30M | 300.00K | -200.00K |
| Total Operating Expenses | 172.40M | 177.30M | 177.30M | 172.50M | 158.60M |
| Operating Income | 9.80M | 3.60M | 500.00K | 2.50M | 8.90M |
| Income Before Tax | 7.60M | 1.20M | -1.20M | -75.90M | 9.70M |
| Income Tax Expenses | 2.50M | 2.50M | 200.00K | 900.00K | 3.10M |
| Earnings from Continuing Operations | 5.10M | -1.30M | -1.40M | -76.80M | 6.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.10M | -1.30M | -1.40M | -76.80M | 6.60M |
| EBIT | 9.80M | 3.60M | 500.00K | 2.50M | 8.90M |
| EBITDA | 20.00M | 13.50M | 9.90M | 12.50M | 18.50M |
| EPS Basic | 0.11 | -0.03 | -0.03 | -1.66 | 0.14 |
| Normalized Basic EPS | 0.11 | 0.03 | -0.01 | 0.01 | 0.11 |
| EPS Diluted | 0.11 | -0.03 | -0.03 | -1.66 | 0.14 |
| Normalized Diluted EPS | 0.11 | 0.03 | -0.01 | 0.01 | 0.11 |
| Average Basic Shares Outstanding | 46.50M | 46.40M | 46.40M | 46.30M | 46.10M |
| Average Diluted Shares Outstanding | 47.50M | 46.40M | 46.40M | 46.30M | 46.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |